Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

You know why you need to put patients at the center from the very beginning of your trials. At Patient-Led Clinical Trials 2017, you’ll discover how.


Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Click here to see who from your team should attend


Sally Chung
Sally Chung

GSK

Project Director

Terttu Haring
Terttu Haring

Sanofi

VP Global Head of Trial Operations

Sam Hariry
Sam Hariry

Novartis

Head of Clinical Strategy - Translational Medicine

Diane Driver
Diane Driver

UCB

Head Outsourcing Contracts Strategic Partnerships

Derek Stewart
Derek Stewart

NIHR

Associate Director for Patient & Public Involvement

Agbor Ndip Ako
Agbor Ndip Ako

GSK

Director Clinical Research

Sheila Khawaja
Sheila Khawaja

WAPO

Board Member, EU Division

Birgit Bauer
Birgit Bauer

Manufaktur für Antworten UG

Journalist – Epatient – Blogger – Patient Speaker – Social media Expert

Trishna Bharadia
Trishna Bharadia

Multiple Sclerosis / Chronic Illness Advocate and Expert Patient

Ali Abbara
Ali Abbara

Imperial College London

Academic Clinical Lecturer

Rémi Chossinand
Rémi Chossinand

Sanofi R&D ITS

Head Clinical Digital Strategy

Jasmine Smith
Jasmine Smith

Epilepsy Society

Trustee

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Clinical Trials – Made by Patients, Owned by Patients

Clinical trials depend on patients and pharma working together. It’s time to work as a team to deliver better outcomes for everyone.

Amazingly, one in ten clinical trials don’t generate a single patient volunteer. And the other nine experience low retention rates. It’s time for this to change. It’s time to put the patients at the center of your clinical trials. When patients own trials, trials become more efficient, generate and retain volunteers, and deliver better outcomes.

At 2017’s only clinical summit designed with and approved by your patients, we’ll work alongside leading pharma experts and patient groups in order to revolutionize the way clinical trials work:

It’s not just about putting patients at the center – you need to put them at the top. Patients must lead and own your trials.

Patient-led Clinical Trials 2017

  • Lead the Revolution
    In 2017, clinical trials will need put patients in charge from the start. Learn from the companies blazing a trail and become a leader in this new clinical revolution
  • Establish the Patient as Your Lead Designer
    Hear from patient advocacy groups who’ll explain how to design trials around your patient – placing their needs as your key design motivation
  • Champion Collaboration
    See how patient advocates can collaborate with you, championing your trials on behalf of your shared cause
  • Adopt a Transparent Approach to Recruitment
    Reliable volunteer recruitment is key to the success of your trial. Explore how to leverage social channels and outreach to ensure participation from motivated, invested patients

What our Delegates are saying

At Patient-led Clinical Trials 2017, patients will lead the way. Pharma knows that clinical trials rely on patient participation, and that greater involvement delivers much more value and efficiency. Patients know that clinical trials help them to access and develop more effective treatments. But despite this mutual need, pharma has found it hard to recruit and retain volunteers, while patients find it difficult to access clinical trials.

At this event in London, representatives from both patient advocacy groups and early adopters of patient-centric trials will co-operate to deliver workable advice on improving your trials in order to facilitate better outcomes and greater returns. From using the social tools at your disposal to raise awareness, to addressing the trust, location and regulatory factors which harm volunteer retention, you’ll receive the strategic information you need to plan patient-led trials which will improve and save lives.

By working together to increase trust and transparency, pharma and patient advocates will be fully equipped to produce more efficient clinical trials which will deliver more effective treatments for a host of serious and life-limiting conditions.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Why Patient-led Clinical Trials?

  • Patient Approved Agenda: Like you, we want to put patients first. So our agenda has been designed, reviewed and approved by a patient panel to ensure it’s hitting the mark.
  • Collaborative setting: 16+ hours of thought provoking debate with all the right stakeholders at one table including pharma, patients, advocacy groups and regulators
  • A learning environment: 2017 will include panel debates, case studies and interactive workshops to ensure you can learn and discuss in multiple ways

Join the 2017 community

Stay updated, receive the latest content and download your brochure here

If you are interested in eyeforpharma Patient-led Clinical Trials please contact us on the below details.

Caitlin Champion

Caitlin Champion

Global Project Director
eyeforpharma

Phone: +44 207 375 7190

Email: caitlin@eyeforpharma.com

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription